Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06397872
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses (6 Days) of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal Function

Who this might be right for
Renal Impairment
Madrigal Pharmaceuticals, Inc. 28
Large-scale testing (Phase 3)Ended earlyNCT01814904
What this trial is testing

Dose-finding Study of MCI-196

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia+1 more
Tanabe Pharma Corporation 10
Not applicableStudy completedNCT00189501
What this trial is testing

A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)

Who this might be right for
Nephrology
Amgen 1,000
Testing effectiveness (Phase 2)Study completedNCT00920764
What this trial is testing

Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 92
Testing effectiveness (Phase 2)Study completedNCT06863467
What this trial is testing

Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease.

Who this might be right for
Renal Insufficiency, ChronicChronic Kidney Disease stage3Chronic Kidney Disease stage4
Revelation Biosciences, Inc 40
Testing effectiveness (Phase 2)Looking for participantsNCT06310967
What this trial is testing

A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease

Who this might be right for
HyperuricemiaHypouricemia, Renal
Intelligem Therapeutics Australia Pty Ltd. 60
Early research (Phase 1)Study completedNCT05505955
What this trial is testing

Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency

Who this might be right for
Glomerulonephritis
Chengdu Suncadia Medicine Co., Ltd. 83
Large-scale testing (Phase 3)Study completedNCT01219855
What this trial is testing

Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismVitamin D Insufficiency
OPKO Health, Inc. 78
Early research (Phase 1)Study completedNCT02775955
What this trial is testing

PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function

Who this might be right for
Healthy
Pharmaceutical Project Solutions, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01658514
What this trial is testing

Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction

Who this might be right for
Renal Insufficiency
Elcelyx Therapeutics, Inc. 39
Early research (Phase 1)Study completedNCT01886599
What this trial is testing

Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 48
Testing effectiveness (Phase 2)Study completedNCT00742716
What this trial is testing

Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 41
Early research (Phase 1)Study completedNCT03542305
What this trial is testing

Lorlatinib Renal Impairment Study

Who this might be right for
Renal Impairment
Pfizer 29
Early research (Phase 1)Study completedNCT02634437
What this trial is testing

Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects

Who this might be right for
Renal Function
Allergan 19
Early research (Phase 1)Study completedNCT05954169
What this trial is testing

Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

Who this might be right for
Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd. 16
Not applicableStudy completedNCT06343129
What this trial is testing

Effects of a Whole-food, Plant-based Nutrition Program on BP and Potassium in Subjects With CKD

Who this might be right for
Chronic Kidney Diseases
University of Rochester 43
Early research (Phase 1)Ended earlyNCT04320771
What this trial is testing

Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Who this might be right for
Pharmacology, Clinical
Bayer 18
Early research (Phase 1)Study completedNCT00426036
What this trial is testing

Effect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of Licarbazepine

Who this might be right for
Healthy
Novartis 12
Testing effectiveness (Phase 2)Study completedNCT01235936
What this trial is testing

Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Who this might be right for
AnemiaKidney Disease
Akebia Therapeutics 10
Large-scale testing (Phase 3)Study completedNCT02341417
What this trial is testing

Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis

Who this might be right for
Secondary Hyperparathyroidism, Chronic Kidney Disease
Amgen 28
Next Page